United States Government Publishing Office
publisher
pbl
distributor
dst
United States
National Archives and Records Administration
Office of the Federal Register
author
aut
Government Organization
text
government publication
eng
FR
Regulatory Information
2016_register
executive
2016-04-02
article
Prospective Grant of Exclusive License: Development of 5T4 Antibodies in Human Cancer Therapeutics and Diagnostics
Notices
D09002ee1c2bb1d69
D09002ee1c2bb1e24
United States
Department of Health and Human Services
originator
org
United States Government Agency or Subagency
United States
National Institutes of Health
originator
org
United States Government Agency or Subagency
This notice, in accordance with 35 U.S.C. 209 and 37 CFR part 404, that the National Cancer Institute, National Institutes of Health, Department of Health and Human Services, is contemplating the grant of an exclusive patent license to practice the inventions embodied in the following U.S. Patents and Patent Applications to Ovensa, Inc. (``Ovensa'') located in Ontario, Canada.
81 FR 19211
https://www.govinfo.gov/app/details/FR-2016-04-04/2016-07556
2016-07556
fr04ap16-112
4140-01-P
https://www.govinfo.gov/app/details/FR-2016-04-04/2016-07556
https://www.govinfo.gov/content/pkg/FR-2016-04-04/html/2016-07556.htm
https://www.govinfo.gov/content/pkg/FR-2016-04-04/pdf/2016-07556.pdf
1 p.
19211
19211
81 FR 19211
Prospective Grant of Exclusive License: Development of 5T4 Antibodies in Human Cancer Therapeutics and Diagnostics; Federal Register Vol. 81, Issue
NOTICE
2016-07556
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
2016-04-19
4140-01-P
2016-07556
Notice.
This notice, in accordance with 35 U.S.C. 209 and 37 CFR part 404, that the National Cancer Institute, National Institutes of Health, Department of Health and Human Services, is contemplating the grant of an exclusive patent license to practice the inventions embodied in the following U.S. Patents and Patent Applications to Ovensa, Inc. (``Ovensa'') located in Ontario, Canada.
Only written comments and/or applications for a license which are received by the Technology Transfer Center at the National Cancer Institute on or before April 19, 2016 will be considered.
Prospective Grant of Exclusive License:
Development of 5T4 Antibodies in Human Cancer Therapeutics and Diagnostics
,
rose.freel@nih.gov
Federal Register
Vol. 81, no. 64
Office of the Federal Register, National Archives and Records Administration
2016-04-04
continuing
daily
deposited
born digital
456 p.
Table of Contents:
AE 2.7:
GS 4.107:
AE 2.106:
KF70.A2
https://www.govinfo.gov/app/details/FR-2016-04-04
P0b002ee18f1a5bd8
0097-6326
0042-1219
0364-1406
769-004-00000-9
000582072
f:fr04ap16
https://www.govinfo.gov/app/details/FR-2016-04-04
https://www.govinfo.gov/content/pkg/FR-2016-04-04/pdf/FR-2016-04-04.pdf
https://www.govinfo.gov/content/pkg/FR-2016-04-04/xml/FR-2016-04-04.xml
fdlp
19021
19466
DGPO
2016-04-02
2023-12-07
FR-2016-04-04
machine generated
eng
FR
FR-2016-04-04
81
64